On December 19, 2014, an order regarding the motion/application for approval of a settlement pursuant to rule 9019 was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1091 and is described on the court’s official docket as follows:
Endorsed Order dated 12/19/2014 Re:  Motion filed by Trustee Paul D. Moore to Approve Compromise. LIMITED NOTICE IS APPROVED AS REQUESTED. (cl)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.